## Anthropic Acquires Stealth Biotech AI Startup Coefficient Bio in $400M Stock Deal
Anthropic, the AI safety and research company, has executed a major strategic acquisition, purchasing the stealth-mode biotech AI startup Coefficient Bio in a deal valued at approximately $400 million, according to reports from The Information and journalist Eric Newcomer. The transaction, structured as a stock deal, signals a significant and unexpected pivot for Anthropic, moving beyond its core focus on large language models and AI safety into the high-stakes, capital-intensive field of biotechnology.

The acquisition of the secretive Coefficient Bio represents a substantial financial commitment and a clear bet on the convergence of AI and biology. While details on Coefficient Bio's specific technology or pipeline remain undisclosed, the sheer size of the deal underscores the perceived value of its AI-driven biotech research. This move places Anthropic in direct competition with other tech giants and specialized biotech firms racing to apply advanced AI to drug discovery, protein engineering, and other life sciences challenges.

The $400 million stock transaction raises immediate questions about Anthropic's long-term strategy and resource allocation. It suggests a deliberate expansion into applied, vertical-specific AI with potentially massive commercial and scientific implications. The deal will likely intensify scrutiny on Anthropic's burn rate and its ability to balance foundational AI research with capital-heavy ventures in regulated industries like biopharma, marking a new chapter of pressure and opportunity for the company.
---
- **Source**: TechCrunch
- **Sector**: The Lab
- **Tags**: AI, Biotechnology, Mergers & Acquisitions, Startups, Venture Capital
- **Credibility**: unverified
- **Published**: 2026-04-03 20:57:10
- **ID**: 49504
- **URL**: https://whisperx.ai/en/intel/49504